Association between sub-unit influenza vaccination and cardiovascular outcomes in patients with acute coronary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20251113003

Enrollment

1206

Registered

2025-11-13

Start date

2025-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome Acute Coronary Syndrome Influenza vaccine Cardiovascular prevention

Interventions

Patients who were older than 20 years, hospitalized with acute coronary syndrome within 30 days, and received standard treatment and the influenza vaccine were included.,Patients who were older than 2

Prevention,Prevention

Influenza vaccine,Non-Influenza vaccine

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 20 years old 2. Patients hospitalized for their initial acute coronary syndrome (ACS) event within 30 days 3. Receive standard treatment

Exclusion criteria

Exclusion criteria: 1. The patient who had advanced heart failure 2. The patient who had advanced liver/kidney disease or disease with limited life expectancy less than 1 year

Design outcomes

Primary

Measure	Time frame
Cardiovascular events 1 year Number of Hospitalization with non-fatal myocardial infarction, non-fatal stroke, heart failure	—

Secondary

Measure	Time frame
All cause death 1 year Number of death	—

Countries

Thailand

Contacts

Public ContactArintaya Phrommintikul

Faculty of Medicine, Chiang Mai University

arintayap@gmail.com053936793

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026